Highlights
KLSE: OMESTI (9008)       OMESTI BHD MAIN : Technology
Last Price Today's Change   Day's Range   Trading Volume
0.44   -0.01 (2.22%)  0.44 - 0.45  278,000
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 234 Million

Market Cap 234 Million
NOSH 532 Million

Latest Audited Result:  31-Mar-2021

Latest Audited Result: 31-Mar-2021
Announcement Date 30-Aug-2021
Next Audited Result: 31-Mar-2022
Est. Ann. Date: 30-Aug-2022
Est. Ann. Due Date: 27-Sep-2022

Latest Quarter:  30-Jun-2021 [#1]

Latest Quarter: 30-Jun-2021 [#1]
Announcement Date 27-Aug-2021
Next Quarter: 30-Sep-2021
Est. Ann. Date: 27-Nov-2021
Est. Ann. Due Date: 29-Nov-2021
QoQ | YoY   57.09%  |    -1,683.52%

Annual (Unaudited) ( EPS: -0.57, P/E: -77.15 )

Revenue | NP to SH 240,300  |  -3,037
RPS | P/RPS 45.13 Cent  |  0.97
EPS | P/E | EY -0.57 Cent  |  -77.15  |  -1.30%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.41  |  1.07
YoY   -112.34%
NP Margin | ROE 1.71%  |  -1.39%
F.Y. | Ann. Date 31-Mar-2021  |  31-May-2021

T4Q Result ( EPS: -0.86, P/E: -51.28 )

Revenue | NP to SH 264,689  |  -4,569
RPS | P/RPS 49.71 Cent  |  0.89
EPS | P/E | EY -0.86 Cent  |  -51.28  |  -1.95%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.38  |  1.15
QoQ | YoY   -50.44%  |    -122.12%
NP Margin | ROE 1.56%  |  -2.24%
F.Y. | Ann. Date 30-Jun-2021  |  27-Aug-2021

Annualized Result ( EPS: -1.08, P/E: -40.65 )

Revenue | NP to SH 266,128  |  -5,764
RPS | P/RPS 49.98 Cent  |  0.88
EPS | P/E | EY -1.08 Cent  |  -40.65  |  -2.46%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -89.79%  |    -1,683.52%
NP Margin | ROE 0.45%  |  -2.83%
F.Y. | Ann. Date 30-Jun-2021  |  27-Aug-2021


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Mar-2022 27-Aug-2021 30-Jun-2021 1 66,532 601 301 -1,441 - 203,779 - % 0.45% -0.71% 532,478 12.49 12.49 -0.27 -0.27 0.00 0.00 0.3827 0.38   57.09%   -1,683.52% 30-Jun-2021 0.44 3.52 -162.59 1.15 -0.62% 0.00% 27-Aug-2021 0.45 3.60 -166.28 1.18 -0.60% 0.00%
31-Mar-2021 31-May-2021 31-Mar-2021 4 56,152 2,253 1,144 -3,358 - 218,447 - % 2.04% -1.54% 531,244 10.57 10.55 -0.63 -0.63 0.00 0.00 0.4112 0.41   -334.97%   -422.24% 31-Mar-2021 0.475 4.49 -75.15 1.16 -1.33% 0.00% 31-May-2021 0.445 4.21 -70.40 1.08 -1.42% 0.00%
31-Mar-2021 26-Feb-2021 31-Dec-2020 3 66,775 328 254 -772 - 202,126 - % 0.38% -0.38% 530,934 12.58 12.54 -0.15 -0.14 0.00 0.00 0.3807 0.38   -177.05%   -181.95% 31-Dec-2020 0.535 4.25 -367.94 1.41 -0.27% 0.00% 26-Feb-2021 0.545 4.33 -374.82 1.43 -0.27% 0.00%
31-Mar-2021 27-Nov-2020 30-Sep-2020 2 75,230 3,361 2,426 1,002 - 185,262 - % 3.22% 0.54% 530,838 14.17 14.13 0.19 0.19 0.00 0.00 0.3490 0.35   1,001.10%   -95.06% 30-Sep-2020 0.49 3.46 259.59 1.40 0.39% 0.00% 27-Nov-2020 0.475 3.35 251.64 1.36 0.40% 0.00%
31-Mar-2021 27-Aug-2020 30-Jun-2020 1 42,143 282 282 91 - 192,481 - % 0.67% 0.05% 530,838 7.94 7.91 0.02 0.02 0.00 0.00 0.3626 0.36   114.15%   -97.76% 30-Jun-2020 0.52 6.55 3,033.36 1.43 0.03% 0.00% 27-Aug-2020 0.66 8.31 3,850.04 1.82 0.03% 0.00%
31-Mar-2020 30-Jun-2020 31-Mar-2020 4 78,212 2,161 601 -643 - 188,697 - % 0.77% -0.34% 478,562 16.34 14.69 -0.13 -0.12 0.00 0.00 0.3943 0.35   -168.26%   -168.33% 31-Mar-2020 0.45 2.75 -334.92 1.14 -0.30% 0.00% 30-Jun-2020 0.52 3.18 -387.02 1.32 -0.26% 0.00%
31-Mar-2020 27-Feb-2020 31-Dec-2019 3 51,829 2,766 2,740 942 - 166,778 - % 5.29% 0.56% 478,561 10.83 9.73 0.20 0.18 0.00 0.00 0.3485 0.31   -95.35%   118.00% 31-Dec-2019 0.52 4.80 264.17 1.49 0.38% 0.00% 27-Feb-2020 0.665 6.14 337.84 1.91 0.30% 0.00%
31-Mar-2020 21-Nov-2019 30-Sep-2019 2 65,306 24,632 21,763 20,267 - 161,773 - % 33.32% 12.53% 477,350 13.68 12.26 4.25 3.81 0.00 0.00 0.3389 0.30   399.93%   369.94% 30-Sep-2019 0.40 2.92 9.42 1.18 10.61% 0.00% 21-Nov-2019 0.505 3.69 11.89 1.49 8.41% 0.00%
31-Mar-2020 27-Aug-2019 30-Jun-2019 1 60,019 4,349 3,923 4,054 - 145,579 - % 6.54% 2.78% 477,781 12.56 11.27 0.85 0.76 0.00 0.00 0.3047 0.27   330.82%   172.82% 28-Jun-2019 0.405 3.22 47.73 1.33 2.10% 0.00% 27-Aug-2019 0.40 3.18 47.14 1.31 2.12% 0.00%
31-Mar-2019 31-May-2019 31-Mar-2019 4 69,009 2,108 1,595 941 - 147,675 - % 2.31% 0.64% 477,295 14.46 12.96 0.20 0.18 0.00 0.00 0.3094 0.28   117.98%   100.90% 29-Mar-2019 0.40 2.77 202.89 1.29 0.49% 0.00% 31-May-2019 0.40 2.77 202.89 1.29 0.49% 0.00%
31-Mar-2019 27-Feb-2019 31-Dec-2018 3 56,076 -6,620 -5,935 -5,234 - 155,375 - % -10.58% -3.37% 461,055 12.16 10.53 -1.14 -0.98 0.00 0.00 0.3370 0.29   30.29%   42.58% 31-Dec-2018 0.41 3.37 -36.12 1.22 -2.77% 0.00% 27-Feb-2019 0.385 3.17 -33.91 1.14 -2.95% 0.00%
31-Mar-2019 30-Nov-2018 30-Sep-2018 2 74,709 -6,447 -7,655 -7,508 - 149,276 - % -10.25% -5.03% 441,646 16.92 14.03 -1.70 -1.41 0.00 0.00 0.3380 0.28   -34.87%   -20.40% 28-Sep-2018 0.42 2.48 -24.71 1.24 -4.05% 0.00% 30-Nov-2018 0.355 2.10 -20.88 1.05 -4.79% 0.00%
31-Mar-2019 28-Aug-2018 30-Jun-2018 1 53,207 -5,723 -5,805 -5,567 - 147,873 - % -10.91% -3.76% 431,873 12.32 9.99 -1.29 -1.05 0.00 0.00 0.3424 0.28   94.70%   -1,110.22% 29-Jun-2018 0.44 3.57 -34.13 1.29 -2.93% 0.00% 28-Aug-2018 0.41 3.33 -31.81 1.20 -3.14% 0.00%
31-Mar-2018 31-May-2018 31-Mar-2018 4 83,751 -127,150 -126,907 -105,083 - 165,274 - % -151.53% -63.58% 431,075 19.43 15.73 -24.38 -19.73 0.00 0.00 0.3834 0.31   -1,052.73%   -2,787.69% 30-Mar-2018 0.455 2.34 -1.87 1.19 -53.58% 0.00% 31-May-2018 0.425 2.19 -1.74 1.11 -57.36% 0.00%
31-Mar-2018 27-Feb-2018 31-Dec-2017 3 88,515 -10,498 -10,695 -9,116 - 273,779 - % -12.08% -3.33% 430,877 20.54 16.62 -2.12 -1.71 0.00 0.00 0.6354 0.51   -46.18%   -1,218.53% 29-Dec-2017 0.53 2.58 -25.05 0.83 -3.99% 0.00% 27-Feb-2018 0.50 2.43 -23.63 0.79 -4.23% 0.00%
31-Mar-2018 30-Nov-2017 30-Sep-2017 2 92,516 -6,074 -6,363 -6,236 - 270,725 - % -6.88% -2.30% 430,543 21.49 17.37 -1.45 -1.17 0.00 0.00 0.6288 0.51   -1,255.65%   -9.00% 29-Sep-2017 0.485 2.26 -33.49 0.77 -2.99% 0.00% 30-Nov-2017 0.51 2.37 -35.21 0.81 -2.84% 0.00%
31-Mar-2018 24-Aug-2017 30-Jun-2017 1 89,191 2,424 1,007 -460 - 276,512 - % 1.13% -0.17% 430,437 20.72 16.75 -0.11 -0.09 0.00 0.00 0.6424 0.52   87.36%   87.10% 30-Jun-2017 0.50 2.41 -467.87 0.78 -0.21% 0.00% 24-Aug-2017 0.50 2.41 -467.87 0.78 -0.21% 0.00%
31-Mar-2017 31-May-2017 31-Mar-2017 4 94,892 -1,977 -1,998 -3,639 - 267,885 - % -2.11% -1.36% 416,878 22.76 17.82 -0.87 -0.68 0.00 0.00 0.6426 0.50   -546.50%   66.75% 31-Mar-2017 0.54 2.37 -61.86 0.84 -1.62% 0.00% 31-May-2017 0.50 2.20 -57.28 0.78 -1.75% 0.00%
31-Mar-2017 23-Feb-2017 31-Dec-2016 3 125,806 2,883 495 815 - 276,522 - % 0.39% 0.29% 412,166 30.52 23.63 0.20 0.15 0.00 0.00 0.6709 0.52   114.25%   146.97% 30-Dec-2016 0.455 1.49 230.10 0.68 0.43% 0.00% 23-Feb-2017 0.455 1.49 230.10 0.68 0.43% 0.00%
31-Mar-2017 29-Nov-2016 30-Sep-2016 2 104,546 -8,134 -9,085 -5,721 - 269,649 - % -8.69% -2.12% 403,667 25.90 19.63 -1.42 -1.07 0.00 0.00 0.6680 0.51   -60.39%   -6.48% 30-Sep-2016 0.475 1.83 -33.52 0.71 -2.98% 0.00% 29-Nov-2016 0.46 1.78 -32.46 0.69 -3.08% 0.00%
31-Mar-2017 30-Aug-2016 30-Jun-2016 1 94,963 -3,903 -4,363 -3,567 - 258,191 - % -4.59% -1.38% 387,850 24.48 17.83 -0.92 -0.67 0.00 0.00 0.6657 0.48   67.40%   49.28% 30-Jun-2016 0.50 2.04 -54.37 0.75 -1.84% 0.00% 30-Aug-2016 0.49 2.00 -53.28 0.74 -1.88% 0.00%
31-Mar-2016 31-May-2016 31-Mar-2016 4 107,399 -15,088 -11,901 -10,943 - 264,626 - % -11.08% -4.14% 388,243 27.66 20.17 -2.82 -2.06 0.00 0.00 0.6816 0.50   -3,416.06%   -333.77% 31-Mar-2016 0.48 1.74 -17.03 0.70 -5.87% 0.00% 31-May-2016 0.48 1.74 -17.03 0.70 -5.87% 0.00%
31-Mar-2016 26-Feb-2016 31-Dec-2015 3 112,692 48 -762 330 2,005 267,120 607.82% -0.68% 0.12% 385,733 29.22 21.16 0.09 0.06 0.52 0.38 0.6925 0.50   106.14%   107.57% 31-Dec-2015 0.515 1.76 601.98 0.74 0.17% 1.01% 26-Feb-2016 0.515 1.76 601.98 0.74 0.17% 1.01%
31-Mar-2016 26-Nov-2015 30-Sep-2015 2 112,775 -4,342 -5,998 -5,373 2,010 258,406 - % -5.32% -2.08% 386,546 29.17 21.18 -1.39 -1.01 0.52 0.38 0.6685 0.49   23.60%   -247.09% 30-Sep-2015 0.52 1.78 -37.41 0.78 -2.67% 1.00% 26-Nov-2015 0.52 1.78 -37.41 0.78 -2.67% 1.00%
31-Mar-2016 28-Aug-2015 30-Jun-2015 1 74,214 -8,040 -9,008 -7,033 - 268,108 - % -12.14% -2.62% 388,563 19.10 13.94 -1.81 -1.32 0.00 0.00 0.6900 0.50   -250.25%   -747.61% 30-Jun-2015 0.65 3.40 -35.91 0.94 -2.78% 0.00% 28-Aug-2015 0.51 2.67 -28.18 0.74 -3.55% 0.00%
31-Mar-2015 29-May-2015 31-Mar-2015 4 100,852 5,705 4,310 4,681 - 268,520 - % 4.27% 1.74% 386,637 26.08 18.94 1.21 0.88 0.00 0.00 0.6945 0.50   207.41%   -61.42% 31-Mar-2015 0.505 1.94 41.71 0.73 2.40% 0.00% 29-May-2015 0.75 2.88 61.95 1.08 1.61% 0.00%
31-Mar-2015 27-Feb-2015 31-Dec-2014 3 119,644 -2,646 -4,524 -4,358 - 256,071 - % -3.78% -1.70% 389,107 30.75 22.47 -1.12 -0.82 0.00 0.00 0.6581 0.48   -181.52%   -132.07% 31-Dec-2014 0.545 1.77 -48.66 0.83 -2.06% 0.00% 27-Feb-2015 0.51 1.66 -45.54 0.77 -2.20% 0.00%
31-Mar-2015 27-Nov-2014 30-Sep-2014 2 120,938 1,573 -191 -1,548 - 259,599 - % -0.16% -0.60% 386,999 31.25 22.71 -0.40 -0.29 0.00 0.00 0.6708 0.49   -242.54%   -127.15% 30-Sep-2014 0.695 2.22 -173.75 1.04 -0.58% 0.00% 27-Nov-2014 0.60 1.92 -150.00 0.89 -0.67% 0.00%
31-Mar-2015 19-Aug-2014 30-Jun-2014 1 94,037 1,610 677 1,086 - 258,778 - % 0.72% 0.42% 387,857 24.25 17.66 0.28 0.20 0.00 0.00 0.6672 0.49   -91.05%   99.27% 30-Jun-2014 0.735 3.03 262.50 1.10 0.38% 0.00% 19-Aug-2014 0.71 2.93 253.57 1.06 0.39% 0.00%
31-Mar-2014 30-May-2014 31-Mar-2014 4 89,217 13,058 12,565 12,132 - 228,512 - % 14.08% 5.31% 341,062 26.16 16.76 3.56 2.28 0.00 0.00 0.6700 0.43   -10.72%   132.24% 31-Mar-2014 0.80 3.06 22.49 1.19 4.45% 0.00% 30-May-2014 0.735 2.81 20.66 1.10 4.84% 0.00%
31-Mar-2014 26-Feb-2014 31-Dec-2013 3 105,425 14,923 13,552 13,588 - 0 - % 12.85% - % 325,069 32.43 19.80 4.18 2.55 0.00 0.00 0.0000 0.00   138.34%   20,180.60% 31-Dec-2013 0.735 2.27 17.58 0.00 5.69% 0.00% 26-Feb-2014 0.75 2.31 17.94 0.00 5.57% 0.00%
31-Mar-2014 20-Nov-2013 30-Sep-2013 2 88,332 7,349 6,584 5,701 - 0 - % 7.45% - % 299,736 29.47 16.59 1.90 1.07 0.00 0.00 0.0000 0.00   946.06%   284.42% 30-Sep-2013 0.69 2.34 36.28 0.00 2.76% 0.00% 20-Nov-2013 0.78 2.65 41.01 0.00 2.44% 0.00%
31-Mar-2014 27-Aug-2013 30-Jun-2013 1 69,312 883 63 545 - 155,077 - % 0.09% 0.35% 247,727 27.98 13.02 0.22 0.10 0.00 0.00 0.6260 0.29   101.45%   113.36% 28-Jun-2013 0.47 1.68 213.64 0.75 0.47% 0.00% 27-Aug-2013 0.67 2.39 304.55 1.07 0.33% 0.00%
31-Mar-2013 30-May-2013 31-Mar-2013 4 109,668 -34,127 -35,364 -37,625 - 139,980 - % -32.25% -26.88% 185,896 58.99 20.60 -20.24 -7.07 0.00 0.00 0.7530 0.26   -56,256.72%   -96.32% 29-Mar-2013 0.655 1.11 -3.24 0.87 -30.90% 0.00% 30-May-2013 0.52 0.88 -2.57 0.69 -38.92% 0.00%
31-Mar-2013 22-Feb-2013 31-Dec-2012 3 79,527 2,414 1,038 67 - 159,342 - % 1.31% 0.04% 167,500 47.48 14.94 0.04 0.01 0.00 0.00 0.9513 0.30   -95.48%   -89.31% 31-Dec-2012 0.70 1.47 1,750.00 0.74 0.06% 0.00% 22-Feb-2013 0.69 1.45 1,725.00 0.73 0.06% 0.00%
31-Mar-2013 23-Nov-2012 30-Sep-2012 2 75,490 2,372 1,416 1,483 - 175,587 - % 1.88% 0.84% 185,374 40.72 14.18 0.80 0.28 0.00 0.00 0.9472 0.33   136.35%   461.71% 28-Sep-2012 0.80 1.96 100.00 0.84 1.00% 0.00% 23-Nov-2012 0.69 1.69 86.25 0.73 1.16% 0.00%
31-Mar-2013 28-Aug-2012 30-Jun-2012 1 73,948 -2,838 -3,926 -4,080 - 174,750 - % -5.31% -2.33% 186,301 39.69 13.89 -2.19 -0.77 0.00 0.00 0.9380 0.33   78.71%   -151.03% 29-Jun-2012 0.94 2.37 -42.92 1.00 -2.33% 0.00% 28-Aug-2012 0.83 2.09 -37.90 0.88 -2.64% 0.00%
31-Mar-2012 28-May-2012 31-Mar-2012 4 84,283 -11,333 -12,154 -19,165 - 178,599 - % -14.42% -10.73% 185,944 45.33 15.83 -10.31 -3.60 0.00 0.00 0.9605 0.34   -3,156.62%   24.44% 30-Mar-2012 0.85 1.88 -8.25 0.88 -12.13% 0.00% 28-May-2012 0.82 1.81 -7.96 0.85 -12.57% 0.00%
31-Mar-2012 23-Feb-2012 31-Dec-2011 3 64,360 811 191 627 - 193,226 - % 0.30% 0.32% 184,411 34.90 12.09 0.34 0.12 0.00 0.00 1.0478 0.36   252.93%   -63.12% 30-Dec-2011 0.86 2.46 252.94 0.82 0.40% 0.00% 23-Feb-2012 0.82 2.35 241.18 0.78 0.41% 0.00%
31-Mar-2012 25-Nov-2011 30-Sep-2011 2 86,479 -900 -2,134 -410 - 194,395 - % -2.47% -0.21% 186,363 46.40 16.24 -0.22 -0.08 0.00 0.00 1.0431 0.37   -105.13%   83.01% 30-Sep-2011 0.76 1.64 -345.45 0.73 -0.29% 0.00% 25-Nov-2011 0.88 1.90 -400.00 0.84 -0.25% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  7 people like this.
 
AlfI3 Lately, mkt had consolidated well. Today shud see some rebound impetus rite?
07/04/2021 6:38 AM
firehawk If buy PB @0.85(RM850), hold to maturity,
250+150 =400.

400 /850 = 4.07%.

5 years return 47.0%, good?
07/04/2021 9:28 AM
firehawk should be better than epf :D
07/04/2021 9:40 AM
jack8 much higher return than Insas-pb
07/04/2021 9:42 AM
wee2000 should rm50+150, right? if u bought 1000 unit, its 1000 x 0.85
dividend is 5% of 1000(based on rm1 PR), should be rm50.
capital gain from PR is 0.15 x 1000 = 150.
07/04/2021 10:42 AM
wee2000 5 yrs of dividend is 5yr x 5% = 25%
capital gain of rm150 over rm850 invested is 17.65%
07/04/2021 10:44 AM
jack8 wee2000, firehawk calculation is base on 5 years, 5 years dividend is 50x5 = 250 + capital gain 150
07/04/2021 10:45 AM
CharlesT Whoever went thru the rights issues also lose money

Looks like not easy to make fm Kok Kee
07/04/2021 10:57 AM
CharlesT Last PR closing price is RM0.115 + Rm1.00-= RM1.115
PA RM0.84 + 2.33 WC (0.11) = RM1.09+
07/04/2021 11:00 AM
wee2000 disappointed after waited for a month on the exercise
07/04/2021 12:15 PM
firehawk PB being sold at such low price, probably could be due to the PR subscription package .... bcos if adding all up PR, PB, WC, is still break even (no loss), so, they can sell the PB at such low price .....

They are people buying subscription rights for a one-off gain, not intend to hold long. They get back their capital and look for other RI ......

Compare to the same type, Insas-PB, Omesti-PB is obviously cheaper ..... while Insas could be in better financial strength, default on this Omesti-PB is quite unlikely. As long as Omesti is capable to redeem, financial strength of the issuers shouldn;t be too much concerned.

Moreover, the proceeds from PB is mainly for funding the project awarded by TM, this is quite a well defined financial borrowing, which makes the default even lower!

Hope the PB price will move up to match those the same type, after the selling wave subsides ...... :-)
08/04/2021 8:19 AM
Peace99 @CharlesT, now the WC @0.15 so untung liao! If mother bought @50sen, can afford to sell PB@70 Sen still makes profit. So, PB can go down more as some ppl may not want to wait 5years!
08/04/2021 1:51 PM
uptrending Money is in the waiting..
Just wait for 1 day only, WC has gone up from 11-12 to 15 :)
08/04/2021 6:50 PM
wee2000 Not practical to get mother at 50c prior to the RI ex-date. Lower ones is at 54c.
Lets just wait, as the PB price is quite illogical at this moment. 5% annual dividend at $1, good prospects in future business.
09/04/2021 8:42 AM
Peace99 @wee2000 Good point. WC shoots up, supposey this means ppl have confidence in company's future. Care to share more of your views of "good prospects"?
09/04/2021 3:10 PM
market101 WC shoots up doesn't reflect ppl confidence in the company. Warrant price usually due to speculations. However the PB price does reflect ppl confidence.The lower the PB price the less the confidence in the company and public perception of default. Just compare Insas PB and Omesti PB .
09/04/2021 5:08 PM
Peace99 @market101 Thanks for explaining. Just now, mother shot up 10% Of course, very happy but wondering what's the push factor?? The most recent news is the court case with SSM. Is it because Omesti has good chance to win?
09/04/2021 5:19 PM
Peace99 I saw Omesti wining quite s few contracts and the RI was to support the 95 mil TM project, that's why I participated in RI!! With this 10%up,breakeven and moving into profit :)
09/04/2021 5:24 PM
caonima vol rise and breaking new high, uptrend soon...
09/04/2021 7:09 PM
Batman_Return Tp rm2.00 can?
09/04/2021 9:13 PM
SaraInvestment warm up only, more to come
10/04/2021 12:17 PM
caonima for those not yet onboard, time to say goodbye...
12/04/2021 10:00 AM
Peace99 https://www.enanyang.my/node/396515
12/04/2021 12:22 PM
Peace99 @market101, As I read more into Omesti, more confident with Omesti. Can't see it defaulting. Besides quite many significant contracts, it's also selected as one of Huawei's partners last year. So will sit back and let Omesti grows :)
12/04/2021 12:37 PM
rwsrws back to 0.495, cant sustain zz
15/04/2021 12:12 PM
Edwardong53 Any one advise whether it is worthwhile to buy Omesti PB + WC instead of the mother shares
25/04/2021 1:28 PM
vanbasten9 i got warrants hehehhehehe
26/04/2021 7:32 PM
marubozuu This is good or goreng counter
26/05/2021 6:42 PM
chaisoonkon limit up sure ,cos microlink QR very good .
28/05/2021 6:25 PM
uptrending https://www.theedgemarkets.com/article/microlink-partners-danapuri-pursue-digital-transformation-projects-west-africa-bangladesh?type=malaysia

Microlink is a 53% subsidiary of Omesti
08/06/2021 8:55 PM
BestOne It's time to fly... good closing at 0.44 tday.. hope more next week!
25/06/2021 5:18 PM
Michael Kwok NO.Putting range of 35-38 cents as buying price.Maybe can reach in 5-10 trading day.After tht Tp price 50 cent range.
04/07/2021 12:22 PM
uptrending Director came out to buy @0.41, 1m; @0.42, 1.025m, @0.43, 60k... More to come, check daily announcements...
08/07/2021 10:56 PM
PennyStock123 once break resistance at 0.465....will fly
16/07/2021 2:43 PM
Peace99 Not bad!
23/07/2021 11:18 AM
rogers123 OMESTI LAUNCHES VACCIN8 PROGRAMME UNDER NEW
HEALTHCARE DIVISION
Technology group OMESTI Berhad has launched the OMESTI Healthcare Vaccin8
Programme to provide vaccination services to companies for their employees as
part of the nationwide drive to combat COVID-19.
The Programme, offered by the OMESTI Healthcare Division, will provide safe and convenient
access to vaccinations for Malaysian companies to protect as many of their employees as
quickly as possible and so help businesses resume normal operations. Authorised by the JKJAV
(Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19) and the Ministry of Health
Malaysia, the Vaccin8 Programme enables OMESTI to lend its support to the National COVID19 Immunisation Programme (NCIP).
Gerard Monteiro, Executive Director of OMESTI Berhad, says, “We are honoured to be able to
do whatever we can to assist in the NCIP and help combat the COVID-19 Pandemic. We firmly
believe that mass-vaccination of the workforce, especially in Malaysia’s critically important
industries, is the only way to protect lives and ensure that livelihoods can be sustained.”
Mr Monteiro adds, “In setting up the OMESTI Healthcare Vaccin8 Programme, we have been
able to leverage our substantial technology heritage in the successful delivery of complex
multi-stakeholder systems to help roll out this vital initiative for the country. The sooner the
majority of the population is protected, the sooner the economy can regain its footing and we
can begin to open up to international business once more.”
OMESTI Berhad has invested in Bemed Tempua Sdn Bhd, a pharmaceutical company which
has been granted approval to acquire an initial allocation of one (1) million doses of the
Sinovac vaccine from Pharmaniaga LifeScience Sdn Bhd.
OMESTI has also engaged the services of licensed healthcare provider Mudah Healthcare Sdn
Bhd (Mudah Healthcare) as its delivery partner for the Vaccin8 Programme. “Our medical
teams will be mobilised to carry out vaccinations on site at company premises, even in remote
locations, offering safety, convenience and flexibility while minimising disruption to business
operations. Appointments can also be arranged at clinics and medical centres convenient to
company premises,” adds Mr Monteiro.
Page 2 of 2
Once completed, all details of the COVID-19 vaccinations provided under the OMESTI Vaccin8
Programme will be reflected in MySejahtera to ensure a reliable and complete ‘single source
of truth’ on the status of vaccinated individuals in Malaysia.
The Vaccin8 Programme has already attracted significant interest from Malaysian companies
and conglomerates in the financial services, plantation, manufacturing and hospitality sectors.
COVID-19 testing services will also be added to the Group’s portfolio in the near future,
enabling companies to conduct mass-testing of employees. This will help contain the risk of
infection, while ensuring compliance with the mandatory requirements for testing that apply
to many industry sectors under the Government SOPs.
Companies that are interested in obtaining vaccinations for their employees simply need to
email vaccin8@omesti.com.
www.vaccin8.omesti.com
……..
About OMESTI
OMESTI Berhad is a Malaysian-based public listed grouping of companies that specialises in helping
clients achieve digital transformation of their operations on both an enterprise-wide and modular basis.
Its portfolio includes proprietary solutions for digital court technology, corporate registry systems and
core banking as well as e-payments, data services, digital HR, cloud applications and IoT solutions.
It is an authorised technology/distribution partner for some of the world’s leading principals including
Huawei, IBM, Lenovo, HPE, Oracle, AWS, Alibaba and Google. It works with large enterprises across
multiple industry sectors including financial institutions, telecommunications, utility and energy firms,
the judiciary, regulatory bodies, education and various government departments. The Group also
provides solutions on an as-a-service basis for e-payments, royalty management, corporate secretarial,
human capital management, and more. www.omesti.com
27/07/2021 11:02 PM
rogers123 Omesti got the vaccine
27/07/2021 11:03 PM
varane What's the target price after this?
28/07/2021 9:21 AM
Peace99 They got 1 million doses of Sinovac....what other vaccines they will be getting?
06/08/2021 5:39 PM
Yu_and_Mee forget about this goreng stock, same as microln and others "stocks" unless you know when to exit.
many loss money because jump in and don't know when to jump out
06/08/2021 8:29 PM
Peace99 But is Omesti not doing honest profitable business?
07/08/2021 5:24 PM
Drachen Post removed. Why?
20/08/2021 11:46 AM
kermit21 @Drachen. link pls.
24/08/2021 11:24 AM
Drachen Post removed. Why?
24/08/2021 11:28 AM
Drachen From Rakuten Trade's Research Hive:
Omesti Bhd (Fundamental BUY with TP 0.71)

Omesti Bhd (Omesti) is primarily involved in providing network connectivity and bandwidth services, and project management services in relation to telecommunications via its 51.8% subsidiary Microlink Bhd.

On 27 July 2021, the company acquired a 70% stake in Bemed Tempua Sdn. Bhd. (Bemed Tempua) for RM700,000 and is now a Covid-19 vaccine provider for the private sector.

Omesti jumped into the Covid-19 vaccine bandwagon and launched the Omesti Healthcare Vaccin8 Programme (“Healthcare Programme”) providing vaccination services to companies for their employees as part of the nationwide drive to achieve herd immunity status.

Authorised by the Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19 (JKJAV) and the Ministry of Health Malaysia (MOH), the 1m doses of Sinovac vaccines acquired from Pharmaniaga enables Omesti to execute its Healthcare Programme. In addition, Omesti is also providing Oral Fluid Antigen Test Kit (approved by the MOH) to existing clients and via online marketing. Demand for its vaccines and test kits remains resilient as the company has already secured substantial orders from companies across different sectors.

Balance sheet is healthy with net cash position of RM27.7m as at FY21.

This new source of income will greatly enhance Omesti’s earnings for FY22 and beyond. BUY with a target price of RM0.71 based on sum of parts valuation, implying a forward PER of 16.5x for FY22. Our BUY recommendation is premised on: (i) strong sales achieved since the launch of Healthcare Programme; (ii) orders secured from the private sectors providing recurring earnings; and (iii) healthy profit margins going forward.
24/08/2021 12:00 PM
Sc Lee very bad company,lossing all the years!
30/08/2021 9:24 AM
PennyStock123 .......1Q net profit 0.301 million (increased 6.74%)......27 Aug 2021 5:08PM
08/09/2021 4:08 PM
PennyStock123 .......Omesti Director....Mr. Monteiro Gerard Clair started to buy....
08/09/2021 4:14 PM
kermit21 @ PennyStock123 how you found out?
10/09/2021 11:08 PM
PennyStock123 ......annoucement available on Bursa website.....https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182926
13/09/2021 8:57 AM